The Authors Reply  by Postorino, Maurizio
Waist circumference and mortality
in dialysis patients: steps to go
To the Editor: We have read with great interest the recently
published article by Postorino et al.1 in Kidney International.
The authors found a bimodal relationship between triglycer-
ides and all-cause and cardiovascular (CV) mortality in
dialysis patients. A ﬁxed (50mg/dl) excess in triglycerides was
associated with a progressive lower risk of all-cause and CV
mortality in patients with threshold waist circumference
(WC) o95 cm, but with a progressive increased risk in those
above this threshold. The authors concluded the predictive
value of triglycerides and cholesterol for survival and
atherosclerotic complications. Although the study is informa-
tive, we have some questions in mind.
First, we wonder whether any information could be given
about Cox regression analysis of the interaction between WC
and triglycerides for predicting all-cause and CV mortality
following increase in the C-reactive protein and albumin
levels, as both of these factors are related to all-cause and CV
mortality in dialysis patients.2 Second, did the authors have
data about the insulin resistances of the patients and did
insulin resistance, apart from WC and triglycerides, have an
independent impact on all-cause and CV mortality?
Lastly, we think that the results of the study would be more
informative if assessment of central fat could be performed by
more reliable methods such as computed tomography and
magnetic resonance imaging.
We believe that the present informative results provided by
Postorino et al. would have been much more valuable with
the addition of the above-mentioned variables in adjusted
analysis if available.
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The Authors Reply: We thank Dr Afsar for his interest1 in
our paper.2 In multivariate models we tested a precise
etiological hypothesis, and for this reason we adjusted for all
variables that met the criteria for being a confounder. C-
reactive protein (CRP) met the criteria for being a confounder
(a detailed description of the characteristics of confounders
was given elsewhere3) for the relationship between cholester-
ol–waist circumference (WC) interaction and study outcomes,
and for this reason it was included in the corresponding Cox
models (see legend to Figure 3). CRP was not included in Cox
analyses based on the triglycerides–WC interaction term
because it was not a confounder for the link between this
interaction term and the study outcomes. In our registry, at
present we have no information on albumin. We have a
residual stored sample and we plan to measure this biomarker
along with new biomarkers at some stage in the future. In any
case, given the strong correlation between albumin and CRP,
it remains to be seen whether the addition of this risk factor
makes sense in modeling the interaction in question.
The hypothesis suggested by Dr Baris regarding the effect
of insulin resistance on adverse clinical outcomes in
hemodialysis (HD) patients is intriguing, but it deserves to
be speciﬁcally addressed in another paper.
The study cohort (n¼ 537) was extracted from the
contemporary HD population (n¼ 1143) included in the
Calabrian registry of dialysis. Computed tomography and
magnetic resonance imaging are too costly and laborious for
being applied in renal registries.
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